z-logo
Premium
Endoscopic dacryocystorhinostomy: long‐term experience and outcomes
Author(s) -
Coumou Adriaan D.,
Genders Stijn W.,
Smid Trudy M.,
Saeed Peerooz
Publication year - 2017
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/aos.13217
Subject(s) - medicine , dacryocystorhinostomy , surgery , demographics , nasolacrimal duct , retrospective cohort study , dacryocystitis , nasolacrimal duct obstruction , complication , sociology , demography
Purpose To report our experience in endoscopic dacryocystorhinostomy in treating nasolacrimal duct obstruction over a 14‐year period. Methods Retrospective case series carried out over a 14‐year period from 1999 to 2014. A total of 624 endoscopic dacryocystorhinostomy procedures were performed in 442 patients who were diagnosed with persistent epiphora. Participants In total, 624 procedures in a total of 442 patients (<18 yo: 36 and >18 yo: 406) were included. Patients' records were assessed for demographics, intra‐ and postoperative complications, outcome and follow‐up. Results In total, 442 patients underwent an endoscopic dacryocystorhinostomy. There were 342 females (77.3%) and 100 males with a mean age of 50.2 years. All patients presented with epiphora: 33 congenital (7.5%), 357 acquired (80.7%) and 52 functional cases (11.8%). The adult dacryocystorhinostomy ( n  = 577) had an anatomical success of 90.1%. Children's group (<18 yo) n  = 36 with a total of 47 procedures and an anatomical success of 91.5%. Functional cases (all adults – n  = 52) showed a 91% benefit after operation. In 624 DCR s, we found a complication rate of 3.2%. Conclusion Endoscopic dacryocystorhinostomy offers good success rates with a safety profile and efficacy equivalent to the traditional external approach is an effective treatment with good outcome results in adults and children with persistent or functional epiphora.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here